MedTrace Logo

Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19

NCT04820803 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-07-07

No results posted yet for this study

Summary

Pilot, randomized and controlled clinical trial for the evaluation of the decrease in the viral load of SARS-CoV-2 in the oropharynx in patients with COVID-19 through the use of mouthwash containing cetylpyridinium chloride (CPC) (0.07%) in mouthwash.

Conditions

Interventions

OTHER

ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE

one mouthwash containing cetylpyridinium chloride (0.07%) for 60 seconds

OTHER

PLACEBO

one mouthwash containing distilled (placebo) water for 60 seconds

Sponsors & Collaborators

  • Dentaid SL

    collaborator INDUSTRY

  • Rosa Tarrago

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-03
Primary Completion
2021-04-29
Completion
2021-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04820803 on ClinicalTrials.gov